The neonatal kidney: Implications for drug metabolism and elimination

Current Drug Metabolism

Volumn 14, Issue 2, 2013, Pages 174-177

  Ligi, I ^a   Boubred, F ^a   Grandvuillemin, I ^a   Simeoni, U ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Drug elimination; Glomerular filtration; Neonatal kidney; Renal clearance; Tubular secretion

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPHOTERICIN B; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA LACTAM ANTIBIOTIC; BETAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; GLUCOCORTICOID; IBUPROFEN; INDOMETACIN; VANCOMYCIN;

ARTERIAL PRESSURE; ARTICLE; CREATININE BLOOD LEVEL; DRUG CLEARANCE; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG URINE LEVEL; GESTATIONAL AGE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; INTRAUTERINE GROWTH RETARDATION; JAUNDICE; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DISORDER; KIDNEY TUBULE EXCRETION; KIDNEY TUBULE FUNCTION; NEONATAL KIDNEY; NEPHRON; NEPHROTOXICITY; NONHUMAN; OLIGURIA; ONTOGENY; PATHOLOGY; PERINATAL ASPHYXIA; PREMATURE LABOR; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; SEPSIS; SIDE EFFECT; TUBULOTOXICITY;

EID: 84877960044     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920013804870592     Document Type: Article

References (19)

1. Boubred, F.; Vendemmia, M.; Garcia-Meric, P.; Buffat, C.; Millet, V.; Simeoni, U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf., 2006, 29(5), 397-419.
2. Aranda, J.; Lulic, M.; Frattarelli, DAC.; Ergun, H.; Tutag-Lehr, V. Drug metabolism and disposition in intrauterine growth retardation, in Développement rénal et programmation des maladies cardiovasculaires, E. SAS, Editor. 2005. p. 113-6.
3. Simeoni, U; Ligi, I.; Buffat, C.; Boubred, F. Adverse consequences of accelerated neonatal growth: cardiovascular and renal issues. Pediatr. Nephrol., 2011, 26(4), 493-508.
4. Rodriguez, M.; Gomez, A.; Abitbol, C. Histomorphometric analysis of postnatal glomerulogenesis on extremely preterm infants. Pediatr. Dev. Pathol., 2004, 7, 17-25. (Pubitemid 38520228)
5. Boubred, F.; Buffat, C.; Feuerstein, JM.; Daniel, L.; Tsimaratos, M.; Oliver, C.; Lelièvre-Pégorier, M.; Simeoni, U. Effects of early postnatal hypernutrition on nephron number and long-term renal function and structure in rats. Am. J. Physiol. Renal Physiol., 2007, 293(6), F1944-9. (Pubitemid 350179619)
6. EMEA. Discussion paper on the impact of renal immaturity when investigating medicinal products intended for paediatric use. 2004: London. p. 1-7. www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/ WC00003807
7. Bestic, M.; Reed, M. The ontogeny of human kidney development: influence on neonatal diuretic therapy. NeoReviews, 2005, 6(8), 363-7.
8. Guignard, J. Agression et protection du rein immature, in Médicaments. Néphrotoxicité. Insuffisance rénale aiguë chez le nouveauné, E. SAS, Editor. 2001, Elsevier SAS. p. 85-94.
9. Gallini, F.; Maggio, L.; Romagnoli, C. Progression of renal function in preterm neonates with gestational age < 32 weeks. Pediatr. Nephrol, 2000, 15, 119-22.
10. Allegaert, K.; Van Den Anker, JN.; Naulaers, G.; De Hoon, J. Determinants of drug metabolism in early neonatal life. Curr. Clin. Pharmacol., 2007, 2, 23-9. (Pubitemid 46723127)
11. Ward, R. Drug disposition in the late preterm ("near-term") newborn. Semin Perinatol., 2006, 30, 48-51.
12. Van Den Anker, J.; Allegaert, K. Renal function and excretion of drugs in the newborn, in Neonatal and Pediatric Pharmacology, L.W.a. Wilkins, Editor. 2010. p. 194-209.
13. Kapur, G.; Mattoo, T.; Aranda, J. Pharmacogenomics and renal drug disposition in the newborn. Semin Perinatol., 2004, 28(2), 132-40. (Pubitemid 38590914)
14. Aranda, J.; Thomas, L. Systematic review: intravenous ibuprofen in preterm newborns. Semin. Perinatol., 2006, 30, 114-20. (Pubitemid 43928131)
15. Langhendries, J.; Van Overmeire, B. Prostaglandines, antiinflammatoires non stéroïdiens (AINS) et rein périnatal: un subtile compromis, in Médicaments. Néphrotoxicité. insuffisance rénale aiguë chez le nouveau-né, E. SAS, Editor. 2001, Elsevier SAS. p. 36-53.
16. Cattarelli, D.; Matis, J.; Simeoni, U. Effets rénaux des corticoïdes administrés en période anténatale ou postnatale, in Médicaments. Néphrotoxicité. Insuffisance rénale aiguë chez le nouveau-né, E. SAS, Editor. 2001, Elsevier SAS. p. 30-35.
17. Langhendries, J. Néphrotoxicité des aminosides, in Médicaments. Néphrotoxicité. Insuffisance rénale aiguë chez le nouveau-né, E. SAS, Editor. 2001, Elsevier SAS. p. 59-77.
18. Reiter, P. Neonatal pharmacology and pharmacokinetics. NeoReviews, 2002. 3(11), 229-36.
19. Zaffanello, M.; Bassareo, PP.; Cataldi, L.; Antonucci, R.; Biban, P.; Fanos, V. Long-term effects of neonatal drugs on the kidney. J. Matern. Fetal Neonatal Med., 2010, 23, 87-9.